COVID-19 vaccine. Should we prioritize efficiency or equity?

In this episode of CareTalk, CareCentrix CEO John Driscoll and I tussle about whether to emphasize equity or efficiency in the rollout of the COVID-19 vaccine. John's in the equity camp while I lean more toward efficiency and broader societal impact and challenge whether there is actually a tradeoff.[embed]https://youtu.be/SKAzqpfphKQ[/embed]